XLR-11
|
XLR-11
(1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone 5-Fluoro UR-144, 5F-UR-144 |
|
| [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
| 1364933-54-9 | |
|
|
InChI=1S/C21H28FNO/c1-20(2)19(21(20,3)4)18(24)16-14-23(13-9-5-8-12-22)17-11-7-6-10-15(16)17/h6-7,10-11,14,19H,5,8-9,12-13H2,1-4H3
|
|
PXLDPUUMIHVLEC-UHFFFAOYSA-N
|
|
|
CC3(C)C(C(=O)c2cn(CCCCCF)c1ccccc12)C3(C)C
|
|
| C21H28FNO | |
| 329.4515 g/mol | |
| 71/II | |
| 2017 | |
|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances. |